Collaboration > Opportunities
Acacia’s internally derived product developments may be available for out-licensing outside Europe once the company has added sufficient value through late stage clinical development. In addition, Acacia is seeking to in-license or acquire clinical stage product developments for supportive care to complement its current development pipeline. If you are interested in discussing the company’s out license opportunities, or have products or product developments you are seeking to divest, please contact Dr Julian Gilbert.